Literature DB >> 23123218

Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Philip D Harvey1, David A Loewenstein, Sara J Czaja.   

Abstract

Long term institutional stay has decreased markedly in people with schizophrenia, although there are still many individuals with a history of long-term institutional stay residing in the community. In addition, although the average duration of acute admissions for schizophrenia is also decreasing, there are indications that psychotic episodes leading to acute admissions are associated with risk for cognitive and functional declines and changes in brain structure. In this paper we review the literature on cognitive changes with aging and institutionalization in schizophrenia, reaching to the conclusion that the reasons for current chronic institutionalization largely include severe psychosis and aggressive behavior. Thus, these factors may be the operative factor in the age-related declines in cognition and functioning reported in this population. We also present evidence to suggest that these changes may be similar to those seen in younger patients who experience repeated psychotic episodes leading to hospitalization. Our conclusion is that there is minimal evidence that hospitalization, long or short, leads to cognitive and functional changes, but rather that the reason for these hospitalizations may underlie cognitive and functional declines. Prevention of relapse and discovering treatments to assist patients with resistant symptoms may reduce the risk of cognitive and functional declines across the lifespan in people with schizophrenia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23123218      PMCID: PMC3574628          DOI: 10.1016/j.nbd.2012.10.022

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  60 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; René C W Mandl; D Louis Collins; Alan C Evans; René S Kahn
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

3.  Characteristics of elderly psychiatric patients retained in a state hospital during downsizing: a prospective study with replication.

Authors:  L White; M Parrella; J McCrystal-Simon; P D Harvey; S J Masiar; M Davidson
Journal:  Int J Geriatr Psychiatry       Date:  1997-04       Impact factor: 3.485

4.  Memory and intellectual deficits do not decline with age in schizophrenia.

Authors:  D Mockler; J Riordan; T Sharma
Journal:  Schizophr Res       Date:  1997-07-25       Impact factor: 4.939

Review 5.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

6.  Social skills performance assessment among older patients with schizophrenia.

Authors:  T L Patterson; S Moscona; C L McKibbin; K Davidson; D V Jeste
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

7.  Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults.

Authors:  David A Loewenstein; Sara J Czaja; Christopher R Bowie; Philip D Harvey
Journal:  Am J Geriatr Psychiatry       Date:  2012-01       Impact factor: 4.105

8.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

9.  Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.

Authors:  Jesus J Gomar; Philip D Harvey; Maria T Bobes-Bascaran; Peter Davies; Terry E Goldberg
Journal:  Am J Geriatr Psychiatry       Date:  2011-11       Impact factor: 4.105

10.  Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia.

Authors:  Natalia Ojeda; Javier Peña; Pedro Sánchez; Edorta Elizagárate; Jesús Ezcurra
Journal:  Schizophr Res       Date:  2008-02-08       Impact factor: 4.939

View more
  5 in total

Review 1.  Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.

Authors:  Philip D Harvey; Stephanie Cosentino; Rosie Curiel; Terry E Goldberg; Jeffrey Kaye; David Loewenstein; Daniel Marson; David Salmon; Keith Wesnes; Holly Posner
Journal:  Innov Clin Neurosci       Date:  2017-02-01

2.  Schizophrenia research in 2013: are we making progress?

Authors:  Takeshi Sakurai; Leslie A Shinobu; Akira Sawa
Journal:  Neurobiol Dis       Date:  2013-02-01       Impact factor: 5.996

3.  Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: A comparison with matched treatment-responsive patients and healthy controls✰,✰✰,★,★★.

Authors:  Junchao Huang; Yu Zhu; Fengmei Fan; Song Chen; Yuan Hong; Yimin Cui; Xingguang Luo; Shuping Tan; Zhiren Wang; Lan Shang; Ying Yuan; Jianxin Zhang; Fude Yang; Chiang-Shan R Li; Laura M Rowland; Peter Kochunov; Fengyu Zhang; L Elliot Hong; Yunlong Tan
Journal:  Psychiatry Res Neuroimaging       Date:  2020-02-04       Impact factor: 2.376

4.  Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.

Authors:  Timothy Peters-Strickland; Ross A Baker; Robert D McQuade; Na Jin; Anna Eramo; Pamela Perry; Brian R Johnson; Anna Duca; Raymond Sanchez
Journal:  NPJ Schizophr       Date:  2015-11-04

5.  Cognition and violent behavior in psychotic disorders: A nationwide case-control study.

Authors:  Jelle Lamsma; Wiepke Cahn; Seena Fazel
Journal:  Schizophr Res Cogn       Date:  2019-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.